We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

Conference

ESGO State of the Art 2018 Conference

October 4-6, 2018 · Lyon, France

soaconference.esgo.org

176 submissions

Menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer

hrt

menopause

delphi

Paget’s disease: biomarkers differences between extra-mammary and mammary diseases

extra mammary paget's disease

The treatment outcome of the combination therapy of high-dose rate intra-cavity brachytherapy (HD-ICBT) and Intensity-modulated radiation therapy (IMRT; TomoTherapy) with central-shielding (CS) for cervical cancer

cervical cancer

imrt

hdr-icbt

Neutropenic septic shock during chemotherapy in gynecologic cancer : Clinical course and characteristics

chemotherapy

septic shock

Challenges in management of neuroendocrine cervical cancer during pregnancy

cervical cancer

neuroendocrine cancer

Catch it Quick: An Audit of the PMB pathway in UHNM

post menopausal bleeding

Single port laparoscopic surgery for adnexal masses

laparoscopy

spl

adnexal mass

A Huge Ovarian Mucinous Cystadenoma, size matters

mucinous

ovarian cyst

large

The Longitudinal Relationship between Ovarian Cancer Survivors Communication of Priority Symptoms and Symptom Severity: Establishing the Need for Appropriate Symptom Communication Patterns

communication

symptom management

Estradiol and follicle stimulating hormone increase cell viability in adult-type ovarian granulosa cell tumor cells – implications for hormonal therapy

granulosa cell tumor

estrogen

fsh

aromatase

Selective cytotoxic effect of non-thermal micro-DBD plasma

non-thermal plasma

cervical cancer

Clinical and genetic characteristics of BRCA1/2 mutation in Korean ovarian cancer patients: A multicenter study and literature review

brca

korean

ovarian cancer

HPV vaccination in Japan: results of a 3-year follow-up survey of obstetricians and gynecologists regarding their opinions toward the vaccine.

the hpv vaccine

cervical cancer

japan

Germline and somatic mutations of homologous recombination associated genes in non-serous ovarian cancer

homologous recombination deficiency

Gynaecological presentation of systemic malignancies

tuboovarian mass

GENE EXPRESSION OF ATP-SYNTHASE AS A PROGNOSTIC FACTOR IN PATIENTS WITH OVARIAN CANCER.

ovarian cancer

atp-synthase

biomarker

Malignant brenner tumor ovary: A Rre Case Report

urothelial epithelium

Phase II study of chemoradiotherapy followed by consolidation chemotherapy using paclitaxel and carboplatin in FIGO stage IIIB/IVA cervical cancer patients

cervical cancer

ccrt

carboplatin

paclitaxel

18F-FDG PET/CT in malignant ovarian germ cell tumors: single-centre experience with long term follow up

malignant germ cell tumor of the ovary

Pure Immature Teratoma of the Ovary, oncologic and fertility outcome of a single center experience

pure immature teratomas

oncologic outcome

Changing a nation: The development and evaluation of a training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients.

ovarian cancer

brca

germline testing

Genomic and functional analysis of Gynecological CarcinoSarcoma

Carcinosarcoma

Genomic landscape

EMT

Impact of the delay and the sequence of adjuvant therapies on outcomes in endometrial carcinoma: a multicentric retrospective study.

endometrial carcinoma

radiotherapy

Progesterone Receptor and PTEN mutation as predictive factors of response to hormone therapy in metastatic endometrial cancer.

Endometrial cancer

Hormone therapy

1 2 3 4 5 6 7 8

Company

Legal

Home About Contact

Imprint Terms of Service Privacy Policy